Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−25.15 M USD
0.00 USD
5.56 M
About Check-Cap Ltd.
Sector
Industry
CEO
David Lontini
Website
Headquarters
Isfiya
Founded
2005
ISIN
IL0011336851
IPO date
Feb 19, 2015
IPO offer price
6.00 USD
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Check-Cap Ltd. stocks are traded under the ticker MBAI.
MBAI stock is 21.74% volatile and has beta coefficient of 2.38. Track Check-Cap Ltd. stock price on the chart and check out the list of the most volatile stocks — is Check-Cap Ltd. there?
Yes, you can track Check-Cap Ltd. financials in yearly and quarterly reports right on TradingView.
Check-Cap Ltd. is going to release the next earnings report on Feb 25, 2026. Keep track of upcoming events with our Earnings Calendar.
No, MBAI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MBAI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Check-Cap Ltd. stock right from TradingView charts — choose your broker and connect to your account.